Clinical Trial Update: A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform [Phase 3]

View source ↗

Summary

Phase 3 trial comparing disease progression and modification after paliperidone palmitate long-acting injectable versus oral antipsychotics in adults with recen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Paliperidone palmitate long-acting injection (paliperidone palmitate)

Snippet

Sponsor: Janssen Scientific Affairs, LLC | Conditions: Schizophrenia, Psychotic Disorders | Phase 3 | Status: COMPLETED | Results posted: 2021-01-19